These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26872535)

  • 41. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer.
    Kato T; Kimura T; Ishii N; Fujii A; Yamamoto K; Kameoka S; Nishikawa T; Kasajima T
    Breast Cancer Res Treat; 1999 Jan; 53(1):19-31. PubMed ID: 10206069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.
    Gluz O; Wild P; Liedtke C; Kates R; Mendrik H; Ehm E; Artinger V; Diallo-Danebrock R; Ting E; Mohrmann S; Poremba C; Harbeck N; Nitz U; Hartmann A; Gaumann A
    Breast Cancer Res Treat; 2011 Apr; 126(3):643-51. PubMed ID: 21318601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic significance of microvessel density in ovarian cancer].
    Rossochacka-Rostalska B; Gisterek IJ; Suder E; Szelachowska JK; Matkowski RA; Lacko A; Kornafel JA
    Wiad Lek; 2007; 60(3-4):129-37. PubMed ID: 17726864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
    Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
    Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
    Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.
    Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K
    Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival.
    Davidson B; Stavnes HT; Førsund M; Berner A; Staff AC
    Breast; 2010 Dec; 19(6):493-8. PubMed ID: 21078485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of HOXD13 expression in human breast cancer.
    Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A distinct microvascular pattern accompanied by aggressive clinical course in breast carcinomas: a fact or a coincidence?
    Safali M; Karslioğlu Y; Arpaci F; Kurt B; Günhan O
    Pathol Res Pract; 2010 Feb; 206(2):93-7. PubMed ID: 19945801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Giercksky KE; Nesland JM
    Clin Cancer Res; 2008 Apr; 14(8):2341-50. PubMed ID: 18413823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
    Yodavudh S; Tangjitgamol S; Puangsa-art S
    J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunohistochemical analysis of angiogenesis in invasive ductal breast carcinoma with correlations to clinicopathological factor].
    Ivković-Kapicl T; Knelević-Usaj S; Panjković M; Mastilović K
    Vojnosanit Pregl; 2006 Jul; 63(7):635-42. PubMed ID: 16875423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.
    Weidner N; Folkman J; Pozza F; Bevilacqua P; Allred EN; Moore DH; Meli S; Gasparini G
    J Natl Cancer Inst; 1992 Dec; 84(24):1875-87. PubMed ID: 1281237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of protein C receptor (PROCR) is associated with inferior clinical outcome in Breast invasive ductal carcinoma.
    Yan Q; Xiaorong Z; Zhang Z; Bing W; Feng Y; Hong B
    Pathol Res Pract; 2017 Sep; 213(9):1173-1179. PubMed ID: 28756987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High ASMA
    Amornsupak K; Jamjuntra P; Warnnissorn M; O-Charoenrat P; Sa-Nguanraksa D; Thuwajit P; Eccles SA; Thuwajit C
    Clin Breast Cancer; 2017 Oct; 17(6):441-452.e2. PubMed ID: 28533055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.